IMRAN AHMED MD NPI 1679650949

NPI Information

  • NPI: 1679650949
  • Provider Name: IMRAN AHMED, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 7445 PEAK DR
    LAS VEGAS, NV
    ZIP 89128
  • Phone: (702) 952-2140

Map and Directions

Get Directions

NPI Details

Imran Ahmed, MD is a hematology and oncology internal medicine in Las Vegas, NV with 33 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Imran Ahmed, MD NPI is 1679650949. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

7445 PEAK DR
LAS VEGAS, NV
ZIP 89128-011
Phone: (702) 952-2140
Fax: (702) 952-2147

The NPI 1679650949 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, lanreotide, 1 mg (HCPCS:J1930)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Protein measurement, serum (HCPCS:84165)
  • Nephelometry, test method using light (HCPCS:83883)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Unclassified drugs (HCPCS:J3490)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
  • Red blood count, automated test (HCPCS:85045)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Thyroid hormone, t3 measurement, free (HCPCS:84481)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Thyroxine (thyroid chemical), total (HCPCS:84436)
  • Folic acid level, serum (HCPCS:82746)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Refilling and maintenance of portable pump (HCPCS:96521)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Haptoglobin (serum protein) level (HCPCS:83010)

The enumeration date for this NPI number is 11/1/2006 and was last updated on 2/23/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology9467NEVADAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1002018509MEDICAIDNEVADA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.